![\"\"](\"https:\/\/blogs.imperial.ac.uk\/doid-staff\/files\/2022\/03\/abt_4738876814948076717MjcyNzQwNg.jpeg\")
<\/p>\n<\/p>\n
Congratulations to all members of the Department who have recently been awarded research grants. Here is our round-up of the latest funding successes.<\/strong><\/span><\/span><\/span><\/span><\/span><\/p>\n Please note, this list comprises awards that have recently been set up on College\u2019s grants management system, with some manual additions. It may not, therefore, include all new grants awarded to Principal Investigators in the Department.<\/em><\/p>\n <\/p>\n","protected":false},"excerpt":{"rendered":" Congratulations to all members of the Department who have recently been awarded research grants. Here is our round-up of the latest funding successes.<\/p>\n","protected":false},"author":1382,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48173],"tags":[],"class_list":["post-724","post","type-post","status-publish","format-standard","hentry","category-uncategorised"],"yoast_head":"\n
\nOctober 2025<\/h2>\n
\n\n
\n Project Lead<\/strong><\/td>\n Funder<\/strong><\/td>\n Scheme<\/strong><\/td>\n Project Title<\/strong><\/td>\n Amount<\/strong><\/td>\n<\/tr>\n \n Robin Shattock<\/td>\n Open Philanthropy<\/td>\n Open Philanthropy<\/td>\n To develop a vaccine candidate for hepatitis C Virus (HCV)<\/td>\n \u00a386,779<\/td>\n<\/tr>\n \n Aran Singanayagam<\/td>\n Astra Zeneca Pharmaceuticals<\/td>\n <\/td>\n Investigation into whether gremubamab can restore Pseudomonas-induced antiviral immune dysregulation in bronchiectasis<\/td>\n \u00a3230,058<\/td>\n<\/tr>\n \n Robin Shattock<\/td>\n Bill & Melinda Gates Foundation<\/td>\n <\/td>\n Development of rotavirus vaccines with self amplifying RNA<\/td>\n \u00a3420,523<\/td>\n<\/tr>\n \n Xiao-Ning Xu<\/td>\n MRC Medical Research Council (MRC)<\/td>\n Molecular and cellular medicine research<\/td>\n Design and evolution of deimmunized protein superglue to enhance modular cell therapy<\/td>\n \u00a3509,852<\/td>\n<\/tr>\n \n Robin Shattock<\/td>\n Bill & Melinda Gates Foundation<\/td>\n Gates<\/td>\n CMV-vectored HIV immunogen in CMV-seronegatives: Exp. Medicine<\/td>\n \u00a3886,061<\/td>\n<\/tr>\n \n Christopher Chiu<\/td>\n National Philanthropic Trust<\/td>\n Flu Lab<\/td>\n \u00a0Single-cell transcriptomics and proteomics in healthy volunteers challenged with influenza A\/H3N2 or live-attenuated influenza virus<\/td>\n \u00a32,251,311<\/td>\n<\/tr>\n \n Jesus Rodriguez Manzano<\/td>\n Boston University<\/td>\n CARB-X<\/td>\n Rapid diagnosis of LRTI aetiology at the point of care using host response multiclass signatures<\/td>\n \u00a3344,818<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n November – December 2025<\/h2>\n
\n\n
\n Project Lead<\/strong><\/td>\n Funder<\/strong><\/td>\n Scheme<\/strong><\/td>\n Project Title<\/strong><\/td>\n Amount<\/strong><\/td>\n<\/tr>\n \n Tim Rawson<\/td>\n Glaxosmithkline Research and Development Ltd<\/td>\n Fleming Initiative \/ GSK partnership<\/td>\n GSK-Fleming Initiative Grand Challenge 4: Precision antimicrobial prescribing in hospitalised patients to achieve the best clinical outcome whilst minimising antimicrobial resistance \u201cdevelopment of a Sequential Multiple Assignment Randomised Trial”<\/td>\n \u00a37,057,879<\/td>\n<\/tr>\n \n Christopher Chiu<\/td>\n Glaxosmithkline Research and Development Ltd<\/td>\n Fleming Initiative \/ GSK partnership<\/td>\n GSK-Fleming Initiative Grand Challenge 5: A human challenge model for Staphylococcus aureus (skin infection and nasal colonisation)<\/td>\n \u00a35,055,015<\/td>\n<\/tr>\n \n Jesus Rodriguez Manzano<\/td>\n Glaxosmithkline Research and Development Ltd<\/td>\n Fleming Initiative \/ GSK partnership<\/td>\n GSK-Fleming Initiative Grand Challenge 1: Predicting future epidemiology<\/td>\n \u00a35,011,988<\/td>\n<\/tr>\n \n James Seddon<\/td>\n Wellcome Trust<\/td>\n Discovery Award<\/td>\n Understanding the immunology, microbiology and morbidity of adolescent tuberculosis<\/td>\n \u00a33,572,684<\/td>\n<\/tr>\n \n Jose Penades<\/td>\n Wellcome Trust<\/td>\n Discovery Awards<\/td>\n Decoding inter-species PICI transfer to understand bacterial evolution and design next-generation antibacterial therapies<\/td>\n \u00a32,754,059<\/td>\n<\/tr>\n \n Alison Holmes<\/td>\n Glaxosmithkline Research and Development Ltd<\/td>\n Fleming Initiative \/ GSK Collaboration<\/td>\n GSK-Fleming Initiative Research Implementation<\/td>\n \u00a32,517,712<\/td>\n<\/tr>\n \n Darius Armstrong-James<\/td>\n Glaxosmithkline Research and Development Ltd<\/td>\n Fleming Initiative<\/td>\n GSK-Fleming Initiative Grand Challenge 3 Antifungal Drug Discovery<\/td>\n \u00a32,499,944<\/td>\n<\/tr>\n \n Jethro Herberg<\/td>\n Innovate UK<\/td>\n 2024 Diagnostic Innovations<\/td>\n CLUE: Classification of LRTIs Using Expression markers<\/td>\n \u00a3702,244<\/td>\n<\/tr>\n \n Kenny Malpartida Cardenas<\/td>\n NIHR National Institute for Health Research<\/td>\n Invention for Innovation i4i THRIVE – April 2025<\/td>\n ViWipe: non-invasive paper-based diagnostics using menstrual blood<\/td>\n \u00a3152,902<\/td>\n<\/tr>\n \n Robin Shattock<\/td>\n Wellcome Leap<\/td>\n <\/td>\n H5N1 Human Antibody Response Study<\/td>\n \u00a386,207<\/td>\n<\/tr>\n \n Aran Singanayagam<\/td>\n LifeArc<\/td>\n Chronic Respiratory Infection Repurposing Award<\/td>\n The EMBARC anti-inflammatory repurposing network (EMBARC-AIRNET)<\/td>\n \u00a350,000<\/td>\n<\/tr>\n \n Jethro Herberg<\/td>\n NHS England<\/td>\n SBRI Emergency and Urgent Care<\/td>\n PREFACE – PRe-Implementation Evaluation of Fidelity and Adherence of the MeMed BV rapid test in febrile Children presenting to the Emergency Department<\/td>\n \u00a342,944<\/td>\n<\/tr>\n \n Jethro Herberg<\/td>\n Rosetrees Trust<\/td>\n 2024 Continuation Funding: Intermediate<\/td>\n INSPECTOR: Integrated Sepsis Point-of-care Evaluation in Resource limited Settings<\/td>\n \u00a333,986<\/td>\n<\/tr>\n \n Akashaditya Das<\/td>\n MRC Medical Research Council (MRC)<\/td>\n Innovation & Collaboration Fund<\/td>\n Expanding CRISPR Oligo Recombineering for classification of non-coding DNA variants<\/td>\n \u00a332,493<\/td>\n<\/tr>\n \n Kenny Malpartida Cardenas<\/td>\n Rosetrees Trust<\/td>\n Seedcorn Award<\/td>\n Paper-based test for genotyping bloodstream bacterial infections<\/td>\n \u00a317,448<\/td>\n<\/tr>\n \n Laura Martin Sancho<\/td>\n CEC Commission of the European Communities<\/td>\n Starting Grant<\/td>\n Rethinking the landscape of host defences against emerging viruses<\/td>\n \u00a31,104,104<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n